Measurement of Plasma and Intracellular Concentrations of Raltegravir in Patients Infected With Human Immunodeficiency Virus.
Phase of Trial: Phase II
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Raltegravir (Primary)
- Indications HIV infections
- Focus Pharmacokinetics
- 12 Nov 2010 Status changed from not yet recruiting to recruiting, according to ClinicalTrials.gov.
- 09 Oct 2010 New trial record